France / Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic Cases; Ipsen Growth
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
France
France / Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race
The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical production back to Europe has hit a wall, Sanofi’s slow progress towards finally bringing its…
COVID-19 Vaccines / Valneva: A Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
News Roundup / French Pharma August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
In Conversation
Nathalie Giraud – Director of Integrated Monitoring Investigator Services (IMIS) & Head of France, PPD
Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance of France in PPD’s overall operations. She also explains how the contract research organization is catering to the needs of biopharma companies and adapting to the ever-changing clinical trials landscape.…
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
Related Report
Stéphane Péden – General Manager, Chamber of Commerce and Industry…
Stéphane Péden, general manager of the Chamber of Commerce & Industry France Taiwan (CCIFT), describes how…
AstraZeneca’s EUR 135 Million Investment in France
On January 21st, 2019, AstraZeneca inaugurated the extension of the group’s industrial site in the city of…
Top Causes of Death in France
Cancer is the leading cause of death in France, accounting for 28.5% of all deaths in 2014, followed by…
Sanofi / USD 679 Million Investment in French Vaccine Manufacturing
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
Artificial IntelliFrance
France is attempting to reposition itself as a globally competitive hub for artificial intelligence R&D, with…
France: A World Leader in Oncology
Due to high unmet medical need, oncology is set to remain as the number one therapeutic area globally in the coming…
Coronavirus / France’s Institut Pasteur; On Course to Develop a Vaccine?
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the…
AMR / France: Becoming a European Vaccination Leader?
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
Brexit: A Window of Opportunity for France’s Drug Regulator?
As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…
‘La French Tech’: France’s new entrepreneurial vibe
Growing awareness of start-up activity within France, fuelled by Minister for the Economy, Industry and Digital…
AI / France's Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on…
France / Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic Cases; Ipsen Growth
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
M&A / Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty Pivot
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
News Roundup / French Pharma August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
Coronavirus / GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
COVID-19 Vaccine / Sanofi CEO Paul Hudson Commits to "Bring a Solution to Everybody, Everywhere"
In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the…
Internationalization / France's Mid-Cap Pharma Champions Look to Global Markets
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma…
Ipsen / New CEO as David Loew Makes Switch From Sanofi Pasteur
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…